Salvage Treatment for HIV- Part I

Salvage treatment for HIV also known as rescue therapy are drug regimens targeting HIV strains that have developed increased resistance to drug combination. Salvage treatment is that drug combo that is employed subsequent to all other combos has shown no improvement.

Salvage Treatment for HIV comes under the following categories:

• Therapy interludes prior to commencing salvage therapy.
• Mega-HAART (MDRT).
• Novel medications or expanded access.
• The reticent strategy – sustain the stable state.

Therapy interludes prior to commencing salvage therapy

A pre-salvage therapy break is taken for numerous reasons, one of which being the mental-emotional advantage of not having to take the medication with a likely respite from the associated side-effects and to allow a break phase to better handle the subsequent medication regimen.

When a therapy break is taken, there might be a reversal to the wild form of virus due to a rise in a tiny existing populace of medication-sensitive HIV which has been restrained by therapy or a form of reverse mutation of drug-defiant HIV to a wild form no sooner has the medication pressure been taken off. By any means, it is presumed that the wild-form HIV would duplicate more swiftly.

Wild-form Virus is the HIV which has not produced any form of mutations and is generally though not always the viral form that a person initially gets infected by.

Latest researches have substantiated that resistant viral forms do not regularly regress to a more medication-vulnerable wild form during the pre-salvage interruption period, and that reversing to wild form is not essentially relating to salvage therapy success. Additionally, researches have indicated that CD4 cell counts plummet during therapy breaks could be sharp and erratic.

More regular medical observation is imperative in case one decides on taking a therapy break. Likely prophylaxis would be necessary for shielding against OI (opportunistic infections), especially in case the CD4 count is at a risk of plummeting under two hundred cells per millimeter cube. The monetary savings from the anti-retroviral combo at the time of the therapy break would be covering the costs of further observational tests.

It is anticipated that therapy break (structured therapy interruption) is chosen for producing an auto-immunization with a person’s own viral form which would aid in jogging the immune system into identifying    HIV as lucidly as it did when the infection was initially contracted. A favorable immune response against HIV could place the viral form into reduction phase on its own and ultimately allowing anti-retroviral therapy to be halted. However, researches till date have solely offered evidence to the likely value of therapy break while indicating a number of diverse shortcomings. Lately, therapy breaks are being endorsed more as a break from medication side-effects instead of being a boost to the immune system.

Popularity: 2% [?]